Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D L Trump

Showing results (111-120 of 145) with videos related to

Pageof 15
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1992
High-dose carboplatin and etoposide with autologous bone marrow transplantation in refractory germ cell cancer: an Eastern Cooperative Oncology Group protocolC R Nichols, J Andersen, H M Lazarus, et al.
Journal of the National Cancer Institute|February 5, 1998
Enhancement of 1,25-dihydroxyvitamin D3-mediated antitumor activity with dexamethasoneW D Yu, M C McElwain, R A Modzelewski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
Modulation of vinblastine resistance in metastatic renal cell carcinoma with cyclosporine A or tamoxifen: a cancer and leukemia group B studyB L Samuels, D R Hollis, G L Rosner, et al.
Annals of Surgical Oncology|November 1, 1995
Phase I/II dose-escalation study of liarozole in patients with stage D, hormone-refractory carcinoma of the prostateE J Seidmon, D L Trump, W Kreis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1987
Platinum analogue combination chemotherapy: cisplatin and carboplatin--a phase I trial with pharmacokinetic assessment of the effect of cisplatin administration on carboplatin excretionD L Trump, J L Grem, K D Tutsch, et al.
Investigational New Drugs|January 1, 1995
A phase II study of interleukin-2 with and without beta-interferon in the treatment of advanced renal cell carcinomaR S Witte, T Leong, M S Ernstoff, et al.
Cancer Chemotherapy and Pharmacology|January 11, 1992
Phase I study of BCNU and intravenous 6-mercaptopurine in patients with anaplastic gliomasD C Smith, N A Vick, D L Trump, et al.
Cancer Research|July 15, 1987
Phase I clinical trial and pharmacokinetic evaluation of acodazole (NSC 305884), an imidazoquinoline derivative with electrophysiological effects on the heartD L Trump, K D Tutsch, J K Willson, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
Phase II trial and pharmacokinetic assessment of intravenous melphalan in patients with advanced prostate cancerD C Smith, D I Jodrell, M J Egorin, et al.
Cancer Treatment Reports|December 1, 1987
Phase I study of taxol administered as a short i.v. infusion daily for 5 daysJ L Grem, K D Tutsch, K J Simon, et al.
Pageof 15

Showing results (111-120 of 145) with videos related to

Sort By:
Pageof 15
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1992
High-dose carboplatin and etoposide with autologous bone marrow transplantation in refractory germ cell cancer: an Eastern Cooperative Oncology Group protocolC R Nichols, J Andersen, H M Lazarus, et al.
Journal of the National Cancer Institute|February 5, 1998
Enhancement of 1,25-dihydroxyvitamin D3-mediated antitumor activity with dexamethasoneW D Yu, M C McElwain, R A Modzelewski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
Modulation of vinblastine resistance in metastatic renal cell carcinoma with cyclosporine A or tamoxifen: a cancer and leukemia group B studyB L Samuels, D R Hollis, G L Rosner, et al.
Annals of Surgical Oncology|November 1, 1995
Phase I/II dose-escalation study of liarozole in patients with stage D, hormone-refractory carcinoma of the prostateE J Seidmon, D L Trump, W Kreis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1987
Platinum analogue combination chemotherapy: cisplatin and carboplatin--a phase I trial with pharmacokinetic assessment of the effect of cisplatin administration on carboplatin excretionD L Trump, J L Grem, K D Tutsch, et al.
Investigational New Drugs|January 1, 1995
A phase II study of interleukin-2 with and without beta-interferon in the treatment of advanced renal cell carcinomaR S Witte, T Leong, M S Ernstoff, et al.
Cancer Chemotherapy and Pharmacology|January 11, 1992
Phase I study of BCNU and intravenous 6-mercaptopurine in patients with anaplastic gliomasD C Smith, N A Vick, D L Trump, et al.
Cancer Research|July 15, 1987
Phase I clinical trial and pharmacokinetic evaluation of acodazole (NSC 305884), an imidazoquinoline derivative with electrophysiological effects on the heartD L Trump, K D Tutsch, J K Willson, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
Phase II trial and pharmacokinetic assessment of intravenous melphalan in patients with advanced prostate cancerD C Smith, D I Jodrell, M J Egorin, et al.
Cancer Treatment Reports|December 1, 1987
Phase I study of taxol administered as a short i.v. infusion daily for 5 daysJ L Grem, K D Tutsch, K J Simon, et al.
Pageof 15